Financing
EQT Life Sciences leads €54 Million Series A Financing of ATB Therapeutics
EQT
PR-11-24-NI-116Nov 20, 2024
Bioscience
Neurocrine Biosciences Presents Breadth of Data Over Time Following Treatment With INGREZZA Capsules
Neurocrine Biosciences
PR-10-24-NI-71Nov 04, 2024
Financing
AbbVie to Acquire Aliada Therapeutics, Strengthening Focus in Alzheimer's Disease and Neuroscience Pipeline
AbbVie
PR-10-24-NI-65Oct 29, 2024
Clinical Trial
Abbott Initiates New Clinical Trial to Improve Outcomes in Patients with Advanced Heart Failure
Abbott
PR-10-24-NI-61Oct 25, 2024
Clinical Development
Children's Hospital of Philadelphia Researchers Find Promising New Immunotherapy Target in Neuroblastoma and Other Cancers
Children's Hospital of Philadelphia
PR-10-24-NI-60Oct 25, 2024
Clinical Development
Dotmatics Introduces Luma Antibody & Protein Engineering Solution for End-to-End Antibody Discovery
Dotmatics
PR-10-24-NI-57Oct 22, 2024
Clinical Trials
INOVIO Announces New Data at Scientific Conferences for Lead Candidate, INO-3107, as a Potential Treatment for RRP
Inovio Pharmaceuticals, Inc.
PR-10-24-NI-53Oct 21, 2024
Clinical Development
MOBILion Systems Unveils Novel High Resolution Mass Spectrometry Functionality for Proteomics Workflows
MOBILion Systems, Inc.
PR-10-24-NI-51Oct 21, 2024
Clinical Trials
Triumvira Immunologics Announces Publication Demonstrating the Safety and Efficacy of TAC T Cells Targeting Claudin 18.2
Triumvira Immunologics Inc.
PR-10-24-NI-47Oct 16, 2024
Clinical Development
Anixa Biosciences appoints Suyasha Gupta as Senior Director of Clinical Development
Anixa Biosciences
PR-10-24-NI-34Oct 07, 2024